Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00786019 · ClinicalTrials.gov registry record · NA

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT00786019 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00786019, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

This study will evaluate the effects of impaired blood flow regulation on exercise. It will also determine whether the effects are more important in the heart or in the skeletal muscle tissue during exercise. In addition, this study will decide whether temporarily reversing these problems will improve blood flow control, improve heart and muscle tissue function and help improve exercise capacity in person with type 2 diabetes. This study will do so using two methods: (1) by giving vitamin C intravenously (IV) and (2) a three month exercise training program. Up to 100 subjects will be enrolled in this study.

Interventions

  • BEHAVIORAL Exercise program
  • DRUG Ascorbic Acid (Vitamin C)

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2008-05
Est. Completion 2011-10
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00786019

The ClinicalTrials.gov registry entry for NCT00786019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Exercise program is the first listed.

NCT00786019 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00786019 about?

NCT00786019 is a clinical study titled "Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes". This study will evaluate the effects of impaired blood flow regulation on exercise. It will also determine whether the effects are more important in the heart or in the skeletal muscle tissue during exercise. In addition, this study will decide whether temporarily reversing these problems will impro...

What is the current status of trial NCT00786019?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2008-05. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00786019?

The interventions under investigation include: Exercise program (BEHAVIORAL), Ascorbic Acid (Vitamin C) (DRUG).

Who is sponsoring clinical trial NCT00786019?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.